JP2007520565A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520565A5
JP2007520565A5 JP2006552282A JP2006552282A JP2007520565A5 JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5 JP 2006552282 A JP2006552282 A JP 2006552282A JP 2006552282 A JP2006552282 A JP 2006552282A JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5
Authority
JP
Japan
Prior art keywords
animal
human
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007520565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/003636 external-priority patent/WO2005077940A1/en
Publication of JP2007520565A publication Critical patent/JP2007520565A/ja
Publication of JP2007520565A5 publication Critical patent/JP2007520565A5/ja
Pending legal-status Critical Current

Links

JP2006552282A 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成 Pending JP2007520565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54207304P 2004-02-04 2004-02-04
US62426204P 2004-11-01 2004-11-01
PCT/US2005/003636 WO2005077940A1 (en) 2004-02-04 2005-02-04 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof

Publications (2)

Publication Number Publication Date
JP2007520565A JP2007520565A (ja) 2007-07-26
JP2007520565A5 true JP2007520565A5 (es) 2008-04-03

Family

ID=34864489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552282A Pending JP2007520565A (ja) 2004-02-04 2005-02-04 デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成

Country Status (9)

Country Link
EP (1) EP1711487A1 (es)
JP (1) JP2007520565A (es)
KR (1) KR101228104B1 (es)
AU (1) AU2005212399B2 (es)
BR (1) BRPI0506655A (es)
CA (1) CA2553630A1 (es)
IL (1) IL176932A0 (es)
NZ (1) NZ548659A (es)
WO (1) WO2005077940A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101049100B1 (ko) 2002-08-02 2011-07-15 니리어스 파마슈티컬즈, 인코퍼레이션 데하이드로페닐아히스틴 및 그의 동족체, 및 이들의 합성방법
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
EP1926724A1 (en) * 2005-09-21 2008-06-04 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN105705148B (zh) * 2013-10-11 2021-03-23 大连万春布林医药有限公司 使用普那布林和紫杉烷的组合的癌症疗法
EP3256130A4 (en) * 2015-02-12 2018-08-01 Beyondspring Pharmaceuticals, Inc. Use of plinabulin in combination with immune checkpoint inhibitors
CA2978679A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
US10238650B2 (en) 2015-03-06 2019-03-26 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
WO2017011399A1 (en) * 2015-07-13 2017-01-19 Beyondspring Pharmaceuticals, Inc Plinabulin compositions
IL260933B2 (en) 2016-02-08 2023-04-01 Beyondspring Pharmaceuticals Inc Preparations containing tocorsol or its analogues
EP3463337A4 (en) 2016-06-06 2020-02-12 Beyondspring Pharmaceuticals, Inc. COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA
CN109563079B (zh) 2016-08-12 2021-10-26 深圳华大海洋科技有限公司 脱氢苯基阿夕斯丁类化合物的多晶型及其制备纯化方法和应用
CN110431135A (zh) 2017-01-06 2019-11-08 大连万春布林医药有限公司 微管蛋白结合化合物及其治疗用途
CA3052190A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
SG11201908420WA (en) * 2017-03-13 2019-10-30 Beyondspring Pharmaceuticals Inc Compositions of plinabulin and use thereof
BR112020014960A2 (pt) 2018-01-24 2020-12-22 Beyondspring Pharmaceuticals, Inc. Composição e método para redução de trombocitopenia
CN108524442B (zh) * 2018-06-05 2022-01-28 深圳海王医药科技研究院有限公司 一种抗肿瘤药物的注射剂及其制备方法
JP2018199726A (ja) * 2018-09-26 2018-12-20 ビヨンドスプリング インコーポレイテッド プリナブリン及びタキサンの組合せがん治療
WO2023060200A1 (en) * 2021-10-07 2023-04-13 Beyondspring Pharmaceuticals, Inc. Methods for treating cancers and tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318789A1 (de) * 1983-05-24 1984-11-29 Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke Deodorant
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
US6069146A (en) * 1998-03-25 2000-05-30 The Regents Of The University Of California Halimide, a cytotoxic marine natural product, and derivatives thereof
US6358957B1 (en) * 1998-11-12 2002-03-19 Nereus Pharmaceuticals, Inc. Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
BRPI0017067B8 (pt) * 2000-01-18 2021-05-25 Beyondspring Pharmaceuticals Inc inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto
KR100852965B1 (ko) * 2000-05-09 2008-08-19 애드파르마 인코포레이티드 피페라진디온 화합물
KR101049100B1 (ko) * 2002-08-02 2011-07-15 니리어스 파마슈티컬즈, 인코퍼레이션 데하이드로페닐아히스틴 및 그의 동족체, 및 이들의 합성방법

Similar Documents

Publication Publication Date Title
JP2007520565A5 (es)
JP2006503588A5 (es)
JP2006524283A5 (es)
JP2009524695A5 (es)
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
JP2003503454A5 (es)
BRPI0714539A2 (pt) "formas farmacêuticas"
JP2010525055A5 (es)
JP2008519810A5 (es)
JP2009504909A5 (es)
JP2008542528A5 (es)
JP2008513426A5 (es)
JP2008517002A5 (es)
JP2006506499A5 (es)
JP2008513427A5 (es)
JP2005524670A5 (es)
JP2009509934A5 (es)
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
JP2006505577A5 (es)
JP2005531640A5 (es)
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
RU2005128615A (ru) Средство для лечения заболеваний пародонта
JP2007508806A5 (es)
JP2007119348A5 (es)